Related Experiment Video
Updated: Nov 4, 2025

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
Published on: August 17, 2022
Liver Transplantation in Children with Urea Cycle Disorders: The Importance of Minimizing Waiting Time
Ioannis A Ziogas1, W Kelly Wu1, Lea K Matsuoka1
1Division of Hepatobiliary Surgery and Liver TransplantationDepartment of SurgeryVanderbilt University Medical CenterNashvilleTN.
Insights
Liver transplantation (LT) corrects urea cycle disorders (UCDs) in children, preventing neurological damage. Early LT evaluation is recommended for optimal outcomes and cognitive development in pediatric UCD patients.
Area of Science:
- Pediatric Hepatology
- Metabolic Disorders
- Transplantation Immunology
Background:
- Urea cycle disorders (UCDs) are genetic conditions causing toxic ammonia buildup.
- Liver transplantation (LT) offers a potential cure for UCDs by replacing the defective organ.
- Neurologic injury is a significant concern in pediatric UCD patients.
Purpose of the Study:
- To analyze the characteristics and outcomes of pediatric liver transplant recipients with UCDs.
- To identify risk factors for graft loss and cognitive delay in this population.
- To evaluate the long-term efficacy of LT in managing UCDs.
Main Methods:
- Retrospective analysis of the United Network for Organ Sharing (UNOS) database.
- Inclusion of pediatric (<18 years) LT candidates with UCDs from February 2002 to September 2020.
- Multivariable Cox and logistic regression models to assess risk factors.
Main Results:
- 95% of 424 pediatric UCD patients underwent LT; 1.9% experienced waitlist mortality.
- 1-, 3-, and 5-year graft survival rates were 90.4%, 86.3%, and 85.2%, respectively.
- Increased weight at LT, male sex, and argininosuccinic aciduria diagnosis were associated with decreased graft loss risk. Waitlist time and male sex increased odds of cognitive delay.
Conclusions:
- Pediatric LT demonstrates excellent long-term graft survival for UCDs.
- Early LT evaluation is crucial to prevent neurologic injury and optimize cognitive outcomes.
- Waitlist duration is a significant risk factor for long-term cognitive delay.
Abstract:
Liver transplantation (LT) for children with urea cycle disorders (UCDs) is capable of correcting the enzymatic defect and preventing progressive neurologic injury. We describe the characteristics and outcomes of pediatric LT recipients with UCDs. We identified all pediatric (<18 years) LT candidates with UCDs in the United Network for Organ Sharing (UNOS) database (February 2002 to September 2020). Multivariable Cox and logistic regression were used to determine risk factors for graft loss and cognitive delay, respectively. Of 424 patients, 1.9% (8/424) experienced waitlist mortality and 95.0% underwent LT (403/424). The most frequently encountered UCDs in our cohort were ornithine transcarbamylase deficiency (46.2%), citrullinemia (20.3%), and argininosuccinic aciduria (ASA; 12.9%). The 1-, 3-, and 5-year graft survival rates were 90.4%, 86.3%, and 85.2%, respectively. Multivariable analysis showed a decreased risk of graft loss with increasing weight at LT (adjusted hazard ratio [aHR], 0.96; 95% confidence interval [CI], 0.94-0.99; P = 0.02), male sex (aHR, 0.49; 95% CI, 0.28-0.85; P = 0.01), and ASA diagnosis (aHR, 0.29; 95% CI, 0.09-0.98; P = 0.047), when adjusting for location (intensive care/hospital/home) and graft type (both P ≥ 0.65). In multivariable logistic regression, waitlist time (adjusted odds ratio [aOR], 1.10; 95% CI, 1.02-1.17; P = 0.009) and male sex (aOR, 1.71; 95% CI, 1.02-2.88; P = 0.04) were associated with increased odds of long-term cognitive delay. Waitlist duration is associated with a long-term risk of cognitive delay. Given excellent long-term outcomes, early LT evaluation should be considered in all children with UCDs to prevent progressive neurologic injury and optimize cognitive outcomes.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Urea Cycle
Kidney Transplant III: Nursing Management
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism

